openPR Logo
Press release

Prostate Cancer Therapeutics Market Global Industry Growth Trends, Upcoming Technologies,Present Market Scenario 2018-2025: Venders are Pfizer, Johnson & Johnson, Astellas Pharma, Bayer, AstraZeneca, Dendreon, AbbVie, Ferring Pharmaceuticals, Endo Pharmac

05-02-2019 01:14 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Prostate Cancer Therapeutics Market – Industry Trends and Forecast to 2025

Global Prostate Cancer Therapeutics Market – Industry Trends and Forecast to 2025

Global PROSTATE CANCER THERAPEUTICS market research report involves a key data and information about the market, emerging trends, product usage, motivating factors for customers and competitors, restraints, brand positioning, and customer behaviour, which is of utmost importance when it comes to achieving a success in the competitive marketplace. Thus, the report deals with plentiful aspects of the ABC industry. This market report provides with CAGR value fluctuation during the forecast period of 2018-2025 for the market. SWOT analysis is the standard, renowned and full-proof method to conduct the market research study which is used to formulate this particular PROSTATE CANCER THERAPEUTICS market report.

Objectives of the marketing research are kept in mind while preparing this PROSTATE CANCER THERAPEUTICS market research report. You should use this market research report to acquire valuable market insights in a cost-effective way. Market segmentation study is carried out in terms of markets covered, geographic scope, years considered for the study, currency and pricing. A comprehensive market research has been conducted in this report which puts a light on the challenges, market structures, opportunities, driving forces, scope, and competitive landscape for your business. The PROSTATE CANCER THERAPEUTICS report aids in achieving an extreme sense of evolving industry movements before the competitors.

The Global Prostate Cancer Therapeutics Market is expected to growing at a CAGR of 12.5% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

To request a sample copy or view summary of this report, click the link below: https://databridgemarketresearch.com/request-a-sample/?dbmr=global-prostate-cancer-therapeutics-market

Global Prostate Cancer Therapeutics Market, By Drug Type (Hormonal Therapy, Luteinizing Hormone-Releasing Hormone (LHRH) Agonist, Anti-
Androgens, Immunotherapy, Targeted Therapy, Chemotherapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends and Forecast to 2025
Increase in research & development in oncology therapeutic area to drive the global prostate cancer therapeutics market is estimated to grow in the forecast period of 2018 to 2025 with the CAGR of 12.5%.

Major Market Competitors/Players: Global Prostate Cancer Therapeutics Market

Some of the major players operating in the global prostate cancer therapeutics market are Tolmar INC, Ferring Pharmaceuticals, Takeda pharmaceutical co. Ltd., Teva Pharmaceutical Industries LTD, Sanofi-Aventis, Pfizer Inc, Johnson & Johnson, IPSEN, Endo Pharmaceuticals Inc (Indevus Pharmaceuticals Inc) , Dendreon Corporation, Bristol-Myers Squibb, Astellas Pharma Inc, Astrazeneca Plc, Active Biotech, Abbott Laboratories, Bayer AG, Dendreon Corporation (Sanpower Group Co. Ltd.), AbbVie, Inc. among others.

Competitive Analysis:

The global prostate cancer therapeutics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of prostate cancer therapeutics market for global, Europe, North America, Asia Pacific and South America.

Major Topics Covered:

1. Introduction
2. Market Segmentation
3. Executive Summary
4. Market Overview
5. Premium Insights
6. Global Prostate Cancer Therapeutics Market: Regulatory Scenario
7. Global Prostate Cancer Therapeutics Market, By Drug Type
8. Global Prostate Cancer Therapeutics Market, By Distribution Channel
9. Global Prostate Cancer Therapeutics Market, By End User
10. Global Prostate Cancer Therapeutics, By Geography
11. Global Prostate Cancer Therapeutics, Company Landscape
12. Company Profiles
13. Related Reports

Any Questions? Inquiry before Buying Visit @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-prostate-cancer-therapeutics-market

Key Developments in the Market:

In May 2018, Ferring Pharmaceuticals has done an agreement giving the company the option to secure global commercialisation rights to nadofaragene firadenovec/Syn3 (rAd-IFN/Syn3), a novel gene therapy that is being developed by FKD Therapies Oy (FKD) as a treatment for patients with high-grade non-muscle invasive bladder cancer (NMIBC), who are unresponsive to Bacillus Calmette-Guérin (BCG) therapy. This option is exercisable on marketing approval from the US FDA. This will create a new US oncology division with the specialist knowledge and presence to introduce novel advanced therapies to the market.

Major Market Drivers and Restraints:

• Innovative drugs driving the market
• Increase in research & development in oncology therapeutic area
• Developments in genomics & proteomics
• Adverse events of treatment
• Cost associated with the treatment
• Low success rate in clinical testing for oncology drugs

Some of the major countries covered in this report are

• U.S.,
• Canada,
• Germany,
• France,
• U.K.,
• Netherlands,
• Switzerland,
• Turkey,
• Russia,
• China,
• India,
• South Korea,
• Japan,
• Australia,
• Singapore,
• Saudi Arabia,
• South Africa
• Brazil among others.

Click Here for Table of Content to Better Understanding of Report @ https://databridgemarketresearch.com/toc/?dbmr=global-prostate-cancer-therapeutics-market

Report Overview:

On the basis of drug type, the market is classified into

• hormonal therapy,
• luteinizing hormone-releasing hormone (LHRH) agonist,
• anti-androgens,
• immunotherapy,
• targeted therapy,
• chemotherapy

On the basis of distribution channel

• hospital pharmacies,
• retail pharmacies,
• online pharmacies

Based on geography

• North America & South America,
• Europe,
• Asia-Pacific
• Middle East & Africa

Questions? We’ll Put You On The Right Path Request Analyst Call @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-prostate-cancer-therapeutics-market

Key questions answered in this report

1. What will be the market size in 2025 and what will the growth rate?
2. What are the key market trends?
3. What is driving this market?
4. What are the challenges to market growth?
5. Who are the key vendors in this market space?

About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prostate Cancer Therapeutics Market Global Industry Growth Trends, Upcoming Technologies,Present Market Scenario 2018-2025: Venders are Pfizer, Johnson & Johnson, Astellas Pharma, Bayer, AstraZeneca, Dendreon, AbbVie, Ferring Pharmaceuticals, Endo Pharmac here

News-ID: 1725258 • Views: 741

More Releases from Data Bridge Market Research

Laser Hair Removal Market Target Audience, Top Key Players 2019 | Solta Medical; …
The research report published by “Data Bridge Market research report provides the all-inclusive data regarding the market with growth, share, size and recent market trends. Worldwide Laser Hair Removal Industry 2019 Market Research Report is spread crosswise over 129 pages and gives restrictive essential insights, information, data, patterns and aggressive scene points of interest in this specialty division.” In this report, Researchers have analyzed Strength, Weakness, opportunities and threats in the
Cold Sore Treatment Market to Witness a Pronounce Growth During 2026: Squarex, M …
Cold Sore Treatment Market 2019, A recent report published by Data Bridge Market Research provides a unique guidance in thoughtful details regarding the development factors, used a top-down and bottom-up approach to keep it error-free and accurate. The researchers have used primary and secondary methodologies to collect data and its analysis. The COLD SORE TREATMENT MARKET data covered in the report will give the reader a comprehensive understanding of the market as well
Fall Detection System Market Trends, Demand and Forecast with Market Players- Li …
Latest Report Most up-to-date research on “Global Fall Detection System Market Insights, Forecast to 2026” to its huge collection of research reports. In this report, Market is expected to reach USD 479.55 Million by 2025 growing at a CAGR of 4.5% in the forecast period 2018 to 2025. Researchers have analyzed Strength, Weakness, opportunities and threats in the market and provides the unbiased picture of the market with the Qualitative and
IoT Connectivity Market 2019 Research Findings, Conclusion, User-Demand, Size, A …
The research report published by “Data Bridge Market research report provides the all-inclusive data regarding the market with growth, share, size and recent market trends. Worldwide IoT Connectivity Industry 2019 Market Research Report is spread crosswise over 129 pages and gives restrictive essential insights, information, data, patterns and aggressive scene points of interest in this specialty division.” In this report, Researchers have analyzed Strength, Weakness, opportunities and threats in the market and provides

All 5 Releases


More Releases for Prostate

Global Prostate Cancer Therapeutics Market
Global Prostate Cancer Therapeutics Market – Industry Analysis and Forecast (2018-2026) –By Product Type, End User, and Region. Global Prostate Cancer Therapeutics Market was valued at US$ 9.21 Bn in 2017 and is expected to reach US$ 16.21 Bn by 2026, at a CAGR of 7.33 % during a forecast period. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data,
Prostate Cancer Drugs Market Research Report 2018
This report studies the global Prostate Cancer Drugs market status and forecast, categorizes the global Prostate Cancer Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-prostate-cancer-drugs-2018-337 The major manufacturers covered in this report AbbVie Astellas Pharma Astra Zeneca Johnson & Johnson Sanofi GlaxoSmithKline Merck Group Novartis Amgen Bayer HealthCare Ferring Pharmaceutical Janssen Pharmaceuticals Endo Pharmaceuticals BMS Takeda
Prostate Biopsy Forceps Market
Global Prostate Biopsy Forceps Market Status and Trend Report offers a comprehensive analysis on Prostate Biopsy Forceps industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Browse Full Report with TOC: http://orbisresearch.com/contacts/request-sample/2072536 Key questions answered by this report include: Worldwide and Regional Market Size of Prostate Biopsy Forceps 2013-2017,
Prostate Cancer - Pipeline Review, H1 2017
Report Hive Market Research Released a New Research Report of 1845 pages on Title " Prostate Cancer - Pipeline Review, H1 2017 "with detailed Analysis, Forecast and Strategies. Prostate Cancer - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer - Pipeline Review, H1 2017, provides an overview of the Prostate Cancer (Oncology) pipeline landscape. Prostate cancer is a form of cancer that affects men and
US Prostate Cancer Drug Pipeline Analysis
Prostate cancer has emerged as one of the most commonly diagnosed cancer among men in the US. According to the American Cancer Society, there were close to 242,000 new cases of prostate cancer in the US in 2012, with 28,000 men dying from it. This was an increase from 206,640 men diagnosed with the condition during 2009. The number of men being actively treated for prostrate disorders such as benign
Global Prostate Biopsy Market 2017-2021
Biopsy is a clinical procedure primarily used in the detection and extraction of malignant or cancerous cells and their abnormal growth in the body for further analysis and interpretation of diseases. The purpose of removing tissues or cells during the procedure is mainly to limit the spread of tumor, minimize morbidity, and eliminate interference with future treatments. Technavios analysts forecast the global prostate biopsy market to grow at a CAGR of